Exploring Analyst Estimates for FMC (FMC) Q4 Earnings, Beyond Revenue and EPS
Werte in diesem Artikel
Wall Street analysts forecast that FMC (FMC) will report quarterly earnings of $1.61 per share in its upcoming release, pointing to a year-over-year increase of 50.5%. It is anticipated that revenues will amount to $1.32 billion, exhibiting an increase of 15.5% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 4.8% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.That said, let's delve into the average estimates of some FMC metrics that Wall Street analysts commonly model and monitor.The consensus estimate for 'Geographic Revenue- Latin America' stands at $516.98 million. The estimate points to a change of +19.5% from the year-ago quarter.Analysts expect 'Geographic Revenue- Europe, Middle East and Africa (EMEA)' to come in at $183.05 million. The estimate suggests a change of +14.7% year over year.Analysts' assessment points toward 'Geographic Revenue- Asia' reaching $273.66 million. The estimate suggests a change of -1.7% year over year.Based on the collective assessment of analysts, 'Geographic Revenue- North America' should arrive at $347.53 million. The estimate points to a change of +26.2% from the year-ago quarter.View all Key Company Metrics for FMC here>>>Over the past month, shares of FMC have returned +14.9% versus the Zacks S&P 500 composite's +2.7% change. Currently, FMC carries a Zacks Rank #5 (Strong Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report FMC Corporation (FMC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf FMC
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf FMC
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Fresenius Medical Care (FMC) St.
Analysen zu Fresenius Medical Care (FMC) St.
Datum | Rating | Analyst | |
---|---|---|---|
31.01.2025 | Fresenius Medical Care (FMC) St Neutral | UBS AG | |
30.01.2025 | Fresenius Medical Care (FMC) St Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
29.01.2025 | Fresenius Medical Care (FMC) St Market-Perform | Bernstein Research | |
28.01.2025 | Fresenius Medical Care (FMC) St Hold | Deutsche Bank AG | |
28.01.2025 | Fresenius Medical Care (FMC) St Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Datum | Rating | Analyst | |
---|---|---|---|
30.01.2025 | Fresenius Medical Care (FMC) St Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
28.01.2025 | Fresenius Medical Care (FMC) St Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
21.01.2025 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. | |
06.12.2024 | Fresenius Medical Care (FMC) St Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
02.12.2024 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
31.01.2025 | Fresenius Medical Care (FMC) St Neutral | UBS AG | |
29.01.2025 | Fresenius Medical Care (FMC) St Market-Perform | Bernstein Research | |
28.01.2025 | Fresenius Medical Care (FMC) St Hold | Deutsche Bank AG | |
27.12.2024 | Fresenius Medical Care (FMC) St Halten | DZ BANK | |
12.12.2024 | Fresenius Medical Care (FMC) St Market-Perform | Bernstein Research |
Datum | Rating | Analyst | |
---|---|---|---|
23.01.2025 | Fresenius Medical Care (FMC) St Underweight | JP Morgan Chase & Co. | |
15.01.2025 | Fresenius Medical Care (FMC) St Underweight | JP Morgan Chase & Co. | |
15.01.2025 | Fresenius Medical Care (FMC) St Underperform | Jefferies & Company Inc. | |
17.12.2024 | Fresenius Medical Care (FMC) St Sell | Warburg Research | |
11.12.2024 | Fresenius Medical Care (FMC) St Underperform | Jefferies & Company Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen